Shinya Fukunishi

Statistics

Publications

102

Citations

3.3K

H-Index

Active since

2009

Affiliations

Osaka Medical and Pharmaceutical University(Current)

Nippon Medical School

Ogaki Municipal Hospital

Saiseikai Niigata Daini Hospital

Ehime Prefectural Central Hospital

Shinya Fukunishi is an author at Osaka Medical and Pharmaceutical University specializing in medicine, oncology, and hepatocellular carcinoma pharmacotherapy.

ORCID

Publications per year

2009–2024

102

Publications

102

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 130 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Andrea Casadei‐Gardini, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2022 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15

Comparison of the clinical impact of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for bile duct obstruction with duodenal obstruction

Takeshi Ogura, Yasutaka Chiba, Daisuke Masuda et al. · Endoscopy · 2015 · 108 citations

Medicine, Internal Medicine, Surgery +16

Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib

Toshifumi Tada, Takashi Kumada, Atsushi Hiraoka et al. · Liver International · 2020 · 97 citations · Full text

Medicine, Oncology, Pharmacology +11

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats

Shinya Fukunishi, Tetsuya Sujishi, Atsushi Takeshita et al. · Journal of Clinical Biochemistry and Nutrition · 2013 · 88 citations · Full text

Medicine, Biochemistry, Pathobiology +12

1–5 of 102